<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Li, Yangling</style></author><author><style face="normal" font="default" size="100%">Zhou, Dongmei</style></author><author><style face="normal" font="default" size="100%">Xu, Shuang</style></author><author><style face="normal" font="default" size="100%">Rao, Mingjun</style></author><author><style face="normal" font="default" size="100%">Zhang, Zuoyan</style></author><author><style face="normal" font="default" size="100%">Wu, Linwen</style></author><author><style face="normal" font="default" size="100%">Zhang, Chong</style></author><author><style face="normal" font="default" size="100%">Lin, Nengming</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Biology &amp;amp; Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2022-07-15 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">1109-1110</style></pages><doi><style  face="normal" font="default" size="100%">10.20892/j.issn.2095-3941.2022.0172</style></doi><volume><style face="normal" font="default" size="100%">19</style></volume><issue><style face="normal" font="default" size="100%">7</style></issue><abstract><style  face="normal" font="default" size="100%">You do not have access to the full text of this article, the first page of the PDF of this article appears above.</style></abstract></record></records></xml>